Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (TAHHT)

This study has been completed.
Pharmacia GmbH, Erlangen, Germany
Baxter Healthcare Corporation
Information provided by:
University Hospital, Saarland Identifier:
First received: December 11, 2009
Last updated: December 12, 2009
Last verified: December 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2002
  Primary Completion Date: August 2002 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):